Robert W Motl1, Edward McAuley, Sean Mullen. 1. Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. robmotl@uiuc.edu
Abstract
OBJECTIVE: One primary assumption underlying the unambiguous interpretation of change in Multiple Sclerosis Walking Scale-12 (MSWS-12) scores over time is longitudinal measurement invariance (i.e., Is the same construct being measured over time?). Such an assumption was tested in the present study over periods of 6 and 12 months in persons with relapsing-remitting multiple sclerosis (RRMS). METHOD: Participants completed a battery of questionnaires that included the MSWS-12 at baseline (n=269) and 6-months (n=260) and 12-months (n=252) follow-up. The data were analyzed using confirmatory factor analysis and a series of nested model comparisons in Mplus 3.0. RESULTS: The results indicated that the unidimensional measurement model and all of its parameters (e.g., factor loadings and item intercepts) were invariant over periods of 6 and 12 months. CONCLUSION: We provide novel evidence that supports the unambiguous interpretation of scores from the MSWS-12 as a measure of change in walking impairment over time in a sample of persons with MS.
OBJECTIVE: One primary assumption underlying the unambiguous interpretation of change in Multiple Sclerosis Walking Scale-12 (MSWS-12) scores over time is longitudinal measurement invariance (i.e., Is the same construct being measured over time?). Such an assumption was tested in the present study over periods of 6 and 12 months in persons with relapsing-remitting multiple sclerosis (RRMS). METHOD:Participants completed a battery of questionnaires that included the MSWS-12 at baseline (n=269) and 6-months (n=260) and 12-months (n=252) follow-up. The data were analyzed using confirmatory factor analysis and a series of nested model comparisons in Mplus 3.0. RESULTS: The results indicated that the unidimensional measurement model and all of its parameters (e.g., factor loadings and item intercepts) were invariant over periods of 6 and 12 months. CONCLUSION: We provide novel evidence that supports the unambiguous interpretation of scores from the MSWS-12 as a measure of change in walking impairment over time in a sample of persons with MS.
Authors: Andrea Giordano; Silvia Testa; Marta Bassi; Sabina Cilia; Antonio Bertolotto; Maria Esmeralda Quartuccio; Erika Pietrolongo; Monica Falautano; Monica Grobberio; Claudia Niccolai; Beatrice Allegri; Rosa Gemma Viterbo; Paolo Confalonieri; Ambra Mara Giovannetti; Eleonora Cocco; Maria Grazia Grasso; Alessandra Lugaresi; Elisa Ferriani; Ugo Nocentini; Mauro Zaffaroni; Alysha De Livera; George Jelinek; Alessandra Solari; Rosalba Rosato Journal: Qual Life Res Date: 2019-11-09 Impact factor: 4.147
Authors: Susan Coote; Stephen Gallagher; Rachel Msetfi; Aidan Larkin; John Newell; Robert W Motl; Sara Hayes Journal: BMC Neurol Date: 2014-12-21 Impact factor: 2.474
Authors: John Zajicek; Susan Ball; David Wright; Jane Vickery; Andrew Nunn; David Miller; Mayam Gomez Cano; David McManus; Sharukh Mallik; Jeremy Hobart Journal: Lancet Neurol Date: 2013-07-13 Impact factor: 44.182
Authors: C Solaro; E Trabucco; A Signori; M Cella; M Messmer Uccelli; G Brichetto; P Cavalla; M Gironi; F Patti; L Prosperini Journal: Mult Scler Int Date: 2015-03-26
Authors: Jan Sørensen; Anne Lee; Brita Løvendahl; Michael Nørgaard; Jette Bay; Peter Vestergaard Rasmussen; Finn Boesen Journal: BMC Health Serv Res Date: 2012-09-06 Impact factor: 2.655
Authors: Sara Hayes; Marcin Kacper Uszynski; Robert W Motl; Stephen Gallagher; Aidan Larkin; John Newell; Carl Scarrott; Susan Coote Journal: BMJ Open Date: 2017-10-12 Impact factor: 2.692